Brief: Evolva gains exclusive license from CDC to develop and commercialise nootkatone
April 5 (Reuters) - Evolva Holding SA EVE.S :
* Gains exclusive license from CDC to develop and
commercialise nootkatone globally for pest control
* Also signs broader nootkatone collaboration agreement with
CDC
Source text for Eikon: ID:nTENpba7ga
Further company coverage: EVE.S
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))
Recent news on EvoNext Holdings SA
See all newsBrief: Evolva Holding: Shareholder Clearway Requests General Meeting
Swiss stocks - Factors to watch on April 15
Brief: Evolva Holding Says shareholders Of Evolva In Liquidation Approve Bod Proposals At AGM
Brief: Evolva And Nice & Green Agree On Improvements To Financing Agreement
Brief: Evolva Holding SA: Initiates Review Of Strategic Alternatives And Revokes Guidance